Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
492
-
Total 13F shares, excl. options
-
18.9M
-
Shares change
-
-197K
-
Total reported value, excl. options
-
$14.1B
-
Value change
-
-$123M
-
Put/Call ratio
-
0.7
-
Number of buys
-
211
-
Number of sells
-
-227
-
Price
-
$745.95
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q3 2021
560 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q3 2021.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 492 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.9M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.27M shares), FMR LLC (1.93M shares), BlackRock Inc. (1.75M shares), STATE STREET CORP (982K shares), BROWN ADVISORY INC (571K shares), ALLIANCEBERNSTEIN L.P. (546K shares), MARSHALL WACE, LLP (439K shares), GEODE CAPITAL MANAGEMENT, LLC (427K shares), ACADIAN ASSET MANAGEMENT LLC (423K shares), and Invesco Ltd. (371K shares).
This table shows the top 492 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.